Wir sind mit live! Mehr erfahren
GMED-Symbol

Globus Medical

76,71 USD
-2,13
2,7 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
76,71
0,00
0 %
1 Tag
-2,7 %
5 Tage
2,43 %
1 Monat
1,93 %
3 Monate
-5,19 %
6 Monate
-17,3 %
Seit Jahresbeginn
-12,13 %
1 Jahr
30,97 %
5 Jahre
0,51 %
10 Jahre
234,1 %
 

Profil: Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Mitarbeiter: 6.000

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 59,1 %
Neutral 38,6 %
Negativ 2,3 %
Neutral
Zacks Investment Research
vor 9 Stunden
GMED or AXGN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or AxoGen (AXGN). But which of these two stocks offers value investors a better bang for their buck right now?
GMED or AXGN: Which Is the Better Value Stock Right Now?
Neutral
GlobeNewsWire
vorgestern
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41st Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, from October 14-17.
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
Neutral
GlobeNewsWire
vor 4 Tagen
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
AUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Positiv
Zacks Investment Research
vor 9 Tagen
Reasons to Add Globus Medical Stock to Your Portfolio Now
GMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal.
Reasons to Add Globus Medical Stock to Your Portfolio Now
Neutral
Zacks Investment Research
vor 10 Tagen
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Globus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Positiv
Zacks Investment Research
vor 11 Tagen
Here's Why Globus Medical (GMED) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Globus Medical (GMED) is a Strong Value Stock
Neutral
Zacks Investment Research
vor 11 Tagen
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
GenAI offers growth opportunities for GMED, ISRG and TMO, but evolving regulations and industry risks are likely to shape adoption.
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
Neutral
Zacks Investment Research
vor 16 Tagen
GMED vs. ITGR: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks offers value investors a better bang for their buck right now?
GMED vs. ITGR: Which Stock Is the Better Value Option?
Positiv
ETF Trends
vor 16 Tagen
The Top HealthTech Questions Landing on Our Desks
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled this guide to answer a mix of the most frequent and most interesting questions we have received regarding our Healthcare Technology and Innovation Index (HTEC).
The Top HealthTech Questions Landing on Our Desks
Positiv
Zacks Investment Research
letzten Monat
What Makes Globus Medical (GMED) a New Strong Buy Stock
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
What Makes Globus Medical (GMED) a New Strong Buy Stock
Kursdiagramme mit Lightweight Charts™ umgesetzt